Since 2018, TMM has tracked Patient-Reported Outcome Measures (PROMs) and Net Promoter Scores (NPS). Results show significant pain reduction, improved mobility, lower stress, and an NPS of 87 — far above the healthcare industry average of 58.
IMPORTANT! All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.
